Related Experiment Videos
Autism: a large unmet medical need and a complex research problem
1Neuroscience Discovery Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.
Physiology & Behavior
|September 5, 2003
Summary
Autism Spectrum Disorder (ASD) affects 1 in 150 children, presenting a significant unmet medical need due to unknown mechanisms. Further preclinical research is crucial for understanding and treating this complex neurodevelopmental condition.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- Autism Spectrum Disorder (ASD) prevalence is increasing, affecting an estimated 1 in 150 children.
- ASD diagnosis is possible by age 2, with patients having a normal lifespan, representing a substantial patient population.
- Despite the significant societal burden and large patient population, no effective treatments exist due to a lack of understanding of ASD mechanisms.
Purpose of the Study:
- To review recent advances in autism research.
- To discuss critical challenges in preclinical autism research.
- To highlight the urgent need for further investigation into ASD.
Main Methods:
- Literature review of recent autism research.
- Analysis of preclinical research challenges and limitations.
- Discussion of the societal and familial impact of ASD.
Main Results:
- The review covers recent progress in understanding ASD.
- Key challenges in preclinical research are identified and discussed.
- The significant burden of ASD on patients, families, and society is emphasized.
Conclusions:
- Understanding the underlying mechanisms of ASD is critical for developing effective treatments.
- Further preclinical research is essential to address the unmet medical needs in ASD.
- Continued research efforts are vital to alleviate the profound impact of ASD.